RTTNews | Aug 2, 2021 07:40AM EDT

07:40 Monday, August 2, 2021 (RTTNews) - Biogen Announces Results From Phase 3b NOVA Study Evaluating Natalizumab In Relapsing-Remitting Multiple Sclerosis

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved